Weyerhaeuser Co (NYSE: WY): The Best-Of-Breed For Investing?

Currently, there are 725.67M common shares owned by the public and among those 722.72M shares have been available to trade.

The company’s stock has a 5-day price change of 3.56% and -17.12% over the past three months. WY shares are trading -9.17% year to date (YTD), with the 12-month market performance down to -18.93% lower. It has a 12-month low price of $24.10 and touched a high of $34.03 over the same period. WY has an average intraday trading volume of 3.83 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.51%, -9.99%, and -15.50% respectively.

Institutional ownership of Weyerhaeuser Co (NYSE: WY) shares accounts for 89.17% of the company’s 725.67M shares outstanding.

It has a market capitalization of $18.56B and a beta (3y monthly) value of 1.17. The stock’s trailing 12-month PE ratio is 51.02, while the earnings-per-share (ttm) stands at $0.50. The company has a PEG of 1.78 and the debt-to-equity ratio at 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.90% over the week and 4.01% over the month.

Analysts forecast that Weyerhaeuser Co (WY) will achieve an EPS of 0.19 for the current quarter, 0.18 for the next quarter and 0.99 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.16 while analysts give the company a high EPS estimate of 0.16. Comparatively, EPS for the current quarter was 0.21 a year ago. Earnings per share for the fiscal year are expected to increase by 23.47%, and 46.41% over the next financial year.

Looking at the support for the WY, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on April 08, 2025, with the firm’s price target at $31. CIBC coverage for the Weyerhaeuser Co (WY) stock in a research note released on January 15, 2025 offered a Sector Outperform rating with a price target of $35. Raymond James was of a view on December 23, 2024 that the stock is Outperform, while BMO Capital Markets gave the stock Outperform rating on December 06, 2024, issuing a price target of $38. Raymond James on their part issued Mkt Perform rating on November 27, 2023.

Most Popular

Related Posts